Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-018624

Options or other derivatives

  • Chief Scientific Officer acquired 103,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lorrain Daniel S. · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-05-24 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
2024-05-24 Grant or award : show line 2 in the form Stock Option (right to buy) +3,700 3,700 I
Loading xslF345X05/rdgdoc.xml…